Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488, 12984 [2022-04787]

Download as PDF 12984 Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. The Drug Enforcement Administration (DEA), Department of Justice, will be submitting the following information collection request to the Office of Management and Budget for review and approval in accordance with the Paperwork Reduction Act of 1995. This information collection is also associated with the proposed rulemaking ‘‘Management of Quotas for Controlled Substances and List I Chemicals,’’ published in the Federal Register. It is likely that the final rule will not be published before this information collection expires on May 31, 2022. If the final rule does publish prior to the expiration, it will be published as the 30-Day Notice. DATES: Comments are encouraged and will be accepted for 60 days until May 9, 2022. FOR FURTHER INFORMATION CONTACT: If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Regulatory Drafting and Policy Support Section (DPW), Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776–2265. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Form 488. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: Pursuant to 21 U.S.C. 952 and 21 CFR 1315.34, any person who desires to import the List I chemicals Ephedrine, Pseudoephedrine, or Phenylpropanolamine during the next calendar year must apply on DEA Form 488 for an import quota for each such List I chemical. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates 49 respondents complete 126 DEA Form 488 applications annually, and that each form takes 0.5 hours to complete. Respondents complete a separate DEA Form 488 for each List I chemical for which quota is sought. Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: March 2, 2022. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2022–04785 Filed 3–7–22; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0047] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 AGENCY: lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:25 Mar 07, 2022 Jkt 256001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates this collection takes a total of 63 annual burden hours. If additional information is required, please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: March 2, 2022. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2022–04787 Filed 3–7–22; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Notice of Lodging Proposed Consent Decree In accordance with Departmental Policy, 28 CFR 50.7, notice is hereby given that a proposed Consent Decree in United States v. Polo Development, Inc., et al., Civil Action No. 4:20–cv–2400– JRA, was lodged with the United States District Court for the Northern District of Ohio on March 1, 2022. This proposed Consent Decree concerns an amended complaint filed by the United States against Defendants Polo Development, Inc., AIM Georgia, LLC, Joseph Zdrilich, Donna Zdrilich, and Carbon Hills, LLC, pursuant to Section 309(b) of the Clean Water Act, 33 U.S.C. 1319(b), to obtain injunctive relief from and impose civil penalties against the Defendants for violating Section 301(a) of the Clean Water Act, 33 U.S.C. 1311(a), by discharging pollutants without a permit into waters of the United States. The proposed Consent Decree resolves these claims by requiring the Defendants to restore impacted areas, record a conservation easement, and pay a civil penalty. The Department of Justice will accept written comments relating to this proposed Consent Decree for thirty (30) days from the date of publication of this Notice. Please address comments to Patrick R. Jacobi, United States Department of Justice, Environment and Natural Resources Division, Environmental Defense Section, Denver Place Building, 999 18th Street, Suite 370—South Terrace, Denver, CO 80202, pubcomment_eds.enrd@usdoj.gov, and refer to United States v. Polo Development, Inc., et al., DJ #’s 90–5–1– 1–21099, 90–5–1–1–22034. Subject to public health protocols, the proposed Consent Decree may be E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Page 12984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04787]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0047]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Application for Import Quota for Ephedrine, 
Pseudoephedrine, and Phenylpropanolamine; DEA Form 488

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA), Department of 
Justice, will be submitting the following information collection 
request to the Office of Management and Budget for review and approval 
in accordance with the Paperwork Reduction Act of 1995. This 
information collection is also associated with the proposed rulemaking 
``Management of Quotas for Controlled Substances and List I 
Chemicals,'' published in the Federal Register. It is likely that the 
final rule will not be published before this information collection 
expires on May 31, 2022. If the final rule does publish prior to the 
expiration, it will be published as the 30-Day Notice.

DATES: Comments are encouraged and will be accepted for 60 days until 
May 9, 2022.

FOR FURTHER INFORMATION CONTACT: If you have comments, especially on 
the estimated public burden or associated response time, suggestions, 
or need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Regulatory Drafting and Policy Support Section (DPW), Diversion Control 
Division, Drug Enforcement Administration; Mailing Address: 8701 
Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776-
2265.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Import Quota for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form 488. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: Pursuant to 21 U.S.C. 952 and 21 CFR 1315.34, any person 
who desires to import the List I chemicals Ephedrine, Pseudoephedrine, 
or Phenylpropanolamine during the next calendar year must apply on DEA 
Form 488 for an import quota for each such List I chemical.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
49 respondents complete 126 DEA Form 488 applications annually, and 
that each form takes 0.5 hours to complete. Respondents complete a 
separate DEA Form 488 for each List I chemical for which quota is 
sought.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates this collection takes a 
total of 63 annual burden hours.
    If additional information is required, please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: March 2, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2022-04787 Filed 3-7-22; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.